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BACKGROUND AND AIMS: Clip closure of the mucosal defect after resecting lar e (≥20 
mm) nonpedunculated colorectal polyps reduces postprocedure bleeding and is cost-saving to 
payers. Clip costs are not reimbursed by payers, posing a major barrier to adoption of this 
technique in the community. We aimed to determine appropriate clip costs to support broader 
use of this procedure in practice. 
METHODS: We performed budget impact analysis using our recent d cision analytic model, 
comparing prophylactic clip closure to no clip closure on national cost and outcomes data, to 
determine the maximum feasible clip price while maint ining cost-savings in practice. 
Sensitivity analyses were performed on important cli ical factors. 
RESULTS: In the original model, the baseline postprocedure ble ding risk was 6.8%, increasing 
cost-of-care by $614.11 averaged among all patients undergoing large polyp resection without 
clip closure. Prophylactic clip closure of only large right-sided polyps reduced postprocedure 
bleeding risk by 70.7% but resulted in cost-saving o ly if price of clips was $100 or less. 
Comparatively, prophylactic clip closure of large left-sided polyps had no clinical benefit and 
was not cost-saving. Clip closure strategies focused on only extra-large polyps (≥40 mm), or 
patients taking antithrombotics regardless of polyp characteristics, were only minimally cost-
saving. Cost-savings and maximum tolerated clip prices depended on medical comorbidity, 
which directly influences the costs-of-care to manage postprocedure bleeding.  
CONCLUSIONS: Prophylactic clip closure after endoscopic resection of large colon polyps, 
particular those in the right colon segment, is cost-saving, but requires clip costs less than $100. 
Translating these findings into practice requires ga troenterology practices to obtain 
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reimbursement from payers for improved clinical outc mes and to align commercial clip prices 
with this clinical indication. 
KEYWORDS: hemoclip, endoclip, endoscopic mucosal resection, pstpolypectomy bleeding, 
cost effectiveness analysis, value 
 
INTRODUCTION 
Endoscopic management of large colon polyps (≥20 mm in diameter) is increasingly 
preferred over surgery as endoscopic mucosal resection has matured as a skill offered in many 
gastroenterology practices1–5. However, postprocedure bleeding, which may requir additional 
evaluation and treatment, remains the most likely adverse event after endoscopic resection6. 
Three randomized controlled trials published earlier this year found that prophylactic endoclip 
closure of a resection bed can reduce bleeding risk after endoscopic resection of large right-sided 
polyps7–9. We recently reported that prophylactic clip closure delivered in a programmatic 
fashion would save $422.98 to Medicare for every patient undergoing large right-sided polyp 
resection, due to lower risks and costs to manage postprocedure bleeding. Despite clear evidence 
of clinical efficacy and cost-savings, the financial pressures on gastroenterology practices of 
routinely placing clips after large polyp resection will likely remain a major challenge to broad 
adoption of this practice. 
 When existing endoscopic technology is re-tooled for a new clinical purpose, 
reimbursement is the usual failure point to adoption.10 Reimbursement for endoscopic equipment 
requires alignment between costs and benefits among payers, practices, and industry. In usual 
fee-for-service arrangements, benefits and costs of prophylactic clipping are misaligned. The 
commercial individual endoclip prices vary between $150 to $200 depending on the 
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manufacturer11, a price likely set according to the traditional use of endoclips in achieving 
hemostasis in which a single endoclip is often sufficient12. In contrast, complete clip closure after 
resecting a large colon polyp can require several clips, adding substantial cost to the management 
of each large polyp resection whereas payer reimbursement to gastroenterology practices 
remains unchanged. 
Thankfully, modern alternative reimbursement pathways can enable practices to 
incorporate clip closure into routine practice.13 Managed care systems, who both (1) insure 
patients against health risks and (2) provide gastroen erology care, are ideally situated to directly 
negotiate clip costs which offset postprocedure bleding costs. Other gastroenterology group 
practices can negotiate with individual payers for additional payment using appropriate modifiers 
(such as modifier-22) to cover equipment costs associated with delivering specialized services to 
patients. Group practices can also consider engagin in professional services agreements with 
hospitals either as part of clinically integrated networks (CIN) to reduce postprocedural 
hospitalization rates, or in the care of patients who are enrolled in accountable care organizations 
(ACOs). However, all of these pathways require evidnce to link appropriate clip prices to cost-
savings associated with improved patient outcomes. 
Using budget impact analysis and threshold pricing techniques, we aimed to determine 
the optimal clip price to support gastroenterology practices, payers, and industry toward 





Recognizing the clinical urgency toward reducing post rocedure bleeding for patients 
undergoing endoscopic large polyp resection through routine prophylactic clip closure, we 
recently reported a brief communication on our development of a decision-analytic model which 
found cost-savings to payers associated with routine prophylactic clip closure of an endoscopic 
resection site from a large (≥20 mm) colon polyp14. Model inputs were derived using a 
systematic review to identify relevant postprocedur bleeding rates and technical aspects of 
performing clip closure in clinical trials. The full methodology for this model is reported 
separately14. The average cost of one bleeding event was $6,458.05 for a 65-year-old patient with 
at least one medical comorbidity, based on demographics of individuals with large colon polyps 
in clinical trials. 
In defining the maximum possible clip price, we assumed that payers could transfer their 
full cost-savings through alternative reimbursement pathways to gastroenterology practices who 
would use those cost-savings to purchase clips. 
 
Programmatic clinical strategies for appropriate clip closure indications 
We evaluated the potential cost-savings associated with several reasonable routine 
clinical strategies for prophylactic clip closure in practice based on patient- and polyp-specific 
factors identified in recent clinical trials: (1) closure of all large colon polyps, (2) closure of 
right-sided polyps only, (3) closure of left-sided polyps only, (4) closure of extra-large polyps 
only (≥40 mm) regardless of location, or (5) closure of all large polyp resection sites (≥20 mm) 






The maximum tolerated commercial clip price was determined using threshold analysis. 
Threshold analysis is a technique used in cost modeling to solve for a missing variable, such that 
net cost-savings would be zero. To accomplish this,we set (cost-savings from reduced 
hospitalization costs due to postprocedure bleeding) = (threshold clip price) x (the distribution of 
the number of clips required to achieve complete clip closure in clinical trials: median of 4 clips; 
range of 1 to 8 clips).7,8,16 Overall, this design assumed that cost-savings would be passed from 
payers to gastroenterology practices and industry through alternative reimbursement pathways. 
Probabilistic sensitivity analysis was performed from a gastroenterology practice 
perspective using 10,000 simulations of the model to assess the probability that routine 
prophylactic clip closure would achieve cost-savings at different clip pricing levels. 
Sensitivity analyses were performed to evaluate howmodel inputs influenced potential 
cost-savings with prophylactic clip closure for each clinical strategy for routine prophylactic clip 
closure. We also conducted analyses on how the presnc  of a major medical comorbidity, or no 
comorbidity, would affect cost-savings, using specific definitions of medical comorbidity 
(known as MC in coding) and major medical comorbidity (known as MMC in coding) outlined 
in the 2019 Centers for Medicare & Medicaid Services (CMS) Final Rule for the Acute Inpatient 
Prospective Payment System26 which directly impacts hospital reimbursements for 
postprocedure bleeding management. 
 
RESULTS 
In our original study, we found a baseline 7.0% risk of postprocedure bleeding after 
resection of a large colon polyp (95% confidence int rval [CI]=4.9-9.7%) based on 2 randomized 
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clinical trials enrolling 899 patients, resulting in $453.44 excess cost for every patient 
undergoing polypectomy to cover the risk of postprocedure bleeding. Polyp location was the 
most important factor in that study. The bleeding risk after resection of right-sided colon polyps 
proximal to or including the hepatic flexure was 9.5% (95% CI, 6.6%-13.2%) and $614.11 
excess cost for these patients, compared to a 1.4% (95 CI, 0.0%-4.9%) bleeding risk after 
resection of left-sided polyps. 
 
Threshold clip prices 
Costs with and without routine prophylactic clip closure and cost-savings to payers are 
reported in Table 1 for each programmatic clinical strategy. Maximum clip prices based on these 
cost-savings are reported in Table 2 for each programmatic clinical strategy. Assuming a median 
number of 4 clips were needed to achieve complete cip closure based on 2 recent RCTs, cost 
savings with routine clip closure after EMR of a large right-sided polyp would require a 
maximum commercial clip price no more than $100 (Figure 1). Routine clip closure after EMR 
of a large left-sided polyp was not cost-saving, so maximum tolerated clip prices were not 
determined. Cost-savings (and lower maximum tolerated clip prices) were lower among patients 
with no medical comorbidities, due to lower costs to manage postprocedure bleeding in these 
patients. Alternative routine clip closure strategies focused on extra-large polyps ≥40 mm in size 
regardless of location, or routine clip closure only after EMR of all large polyps ≥20 mm in 
patients on antithrombotics, resulted in 62.9% and 69.2% respective risk reductions in 
postprocedure bleeding; however, the absolute decrease in risk was small. Thus, current 
commercial clip prices did not support cost-savings for routine prophylactic clip closure with 
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these strategies, which necessitated clip prices no greater than $11 to $21 per clip to achieve 
cost-savings in practice. 
In addition to polyp location, cost-savings and maximum tolerated clip prices were also 
dependent on medical comorbidities. Patients with major medical comorbidities, as defined by 
CMS, necessitated higher reimbursements for management of postprocedure bleeding, had 
higher potential cost-savings and higher tolerated clip prices with routine prophylactic clip 
closure.  
 
Likelihood of cost-savings to gastroenterology practices with prophylactic clip closure depends 
on clip price 
We modeled the likelihood of cost-savings at various clip prices, based on the clinical 
strategy for routine prophylactic clip closure (Figure 2). Routine clip closure after right-sided 
polypectomy was the only clinical strategy which was cost-saving at a clip price of $50. Above 
$75 per clip, no clinical strategy for routine prophylactic clip closure resulted in cost-savings 
more than 50% of the time. 
 
Sensitivity analysis on model inputs 
The preference for each clinical clip closure strategy based on whether cost-savings is 
achieved is shown in Figure 3, varied by cost of postprocedure bleeding, theoretical clip price, 
and technical success of achieving complete clip closure. Clip closure after EMR of right-sided 
polyps was increasingly preferred for patients with a greater number of medical comorbidities, 
represented by increasing costs to manage postprocedure bleeding (left pane). Higher technical 
success of the endoscopist in achieving complete clip closure did not influence cost-savings 
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preference toward clip closure or maximum tolerated clip prices. Clip closure among patients on 
antithrombotics, as well as clip closure in the left colon segment, were not preferred clinical 
strategies regardless of the cost to manage postprocedure bleeding. 
 
DISCUSSION 
We used budget impact and threshold pricing techniques to determine the maximum 
tolerated pricing for endoclips to support routine prophylactic clip closure after resecting large 
colon polyps. We found that clip prices less than $100 would be needed to support routine clip 
closure of large right-sided polyps, recognizing that in reality even this price may need to be 
shared among 3 stakeholders: payers, GI practices, and industry. Routine clip closure of left-
sided polyps would not decrease postprocedure bleeding rates and was not cost-saving. 
Prophylactic clip closure strategies focused on only extra-large polyps ≥40 mm in size regardless 
of location, or routine clip closure only after EMR of all large polyps ≥20 mm in patients on 
antithrombotics, would require marked reduction in cl p price to achieve cost-savings to 
gastroenterology practices. 
Reimbursement is often the major barrier to broad adoption of promising advanced 
endoscopic techniques, especially when these techniques use known endoscopic 
technologies.17,18 This is especially disconcerting when clinical outcomes with such techniques 
are apparent, the technology is well known, and the technology is readily available in most 
endoscopy centers. Payers usually reimburse gastroente logy practices for endoscopic 
procedures under a fixed fee-for-service model, using a global service code intended to cover the 
costs of equipment, personnel including sedation staff, and facilities.19 To offer the appropriate 
endoscopic care (and to avoid morbidities associated with surgery to the patient),20 
9 
 
gastroenterology practices must be able to absorb the additional costs within a fixed fee-for-
service budget. Supporting routine prophylactic clip osure financially would require payers to 
either (1) transfer cost-savings to gastroenterology practices from through one of several 
contemporary alternative reimbursement pathways or (2) improve reimbursement through 
traditional fee-for-service mechanisms. Furthermore, clip prices would need to realigned with 
this clinical use.  
There are likely other potential hidden financial benefits beyond reducing postprocedure 
bleeding by enabling reimbursement for endoscopic clip placement, to the extent that cases are 
shifted to endoscopy from surgery. As an example, th re were 3 delayed perforations in the non-
clipped arm in contrast to no delayed perforations in the clipped arm of Pohl et al7. The result of 
these factors is that endoscopists may be willing to undertake endoscopic resection because of 
decreased fear of adverse events. 
Endoscopic clips remain the most widely used and widely studied modality to prevent 
postprocedure bleeding after endoscopic resection of complex colorectal polyps; however, 
complete closure of large or irregularly shaped defects may not be feasible in some patients, 
which is certainly a limitation of this approach. Alternative etiologies to prevent postprocedure 
bleeding exist but remain less well studied. Conceptually, over-the-scope (OTS) clipping devices 
could be used to close postresection defects although p blished data are nonexistent. 
Furthermore, OTS clips are costly and not available t many institutions. There are limited, but 
promising, data describing the use of a novel biocompatible synthetic extracellular matrix 
(Purastat, 3D Matrix, Waltham, Mass, USA) that can be applied to the resection defect to prevent 
delayed bleeding.21 This self-assembling microstructure is delivered in a soluble form with 
conversion to a hydrogel matrix upon luminal contact with a goal to promote tissue regeneration. 
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Another approach involves endoscopic suturing to close the resection site.22 The most promising 
approach to prevention of postprocedure bleeding after mucosal resection is the development of 
cold snare EMR.23 This technique mirrors conventional EMR in every way except that tissue is 
resected using mechanical force in lieu of electrocautery. The tenets of this technique lie in the 
supposition that most postprocedure adverse events (i , bleeding, perforation) are related to 
electrocautery injuries. A recent systematic review of case-series data found complete resection 
rates of 99.3% with no perforations or postprocedur bleeding events.24 Although this approach 
is promising, further evaluation is desperately needed to determine its role in resection of 
complex colon polyps.  
There are several important considerations regarding application of these findings in 
practice. First, our proposed clip prices are thresold prices that assume full transfer of cost-
savings from lower hospitalization rates for postprocedure bleeding toward purchasing 
endoclips. In reality, gastroenterology practices should also consider how adding clip closure to 
their practice would impact their personnel costs and other endoscopic/anesthesia equipment 
costs, factors which would may lower the maximum tolerated clip price. Practices should also 
consider their local payer mix and geographic variation in reimbursement because even Medicare 
reimbursement varies by specific rural and geographic multipliers compared with the national 
average Medicare reimbursement reported in our present analysis. Because the aim of the 
endoscopist in underlying trials was to achieve complete clip closure, our findings cannot 
support any alternative clinical protocol (such as routine incomplete closure) in achieving the 
potential bleeding risk reductions or cost-savings reported here. Finally, it is important to 
recognize that this analysis is intended solely to support dissemination of this clinically effective 
technique supported by recent clinical trials. 
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In this study, we used budget impact and threshold pricing techniques to determine the 
maximum tolerated clip prices to enable routine prophylactic clip closure after resection of large 
colon polyps. The study strengths include adherence to methodologic guidelines, inclusion of 
both payer and gastroenterology practice perspectives on whom expected cost-savings might 
have the greatest potential influence, and the use of national reimbursement data and common 
reimbursement codes to improve generalizability of our study findings. Our study determined 
that prophylactic clip closure strategy after resection of large right-sided nonpedunculated colon 
polyps is the optimal cost-saving strategy but requires clip costs <$100. These findings provide a 
model for gastroenterology practices to pursue alterna ive reimbursement means and appropriate 
endoclip acquisition to support prophylactic clip closure as a clinically effective and innovative 
technique in routine practice. 
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Figure 1: Maximum commercial clip prices to enable routine prophylactic clip closure. These 
prices assume that payers could pass cost-savings from reduced hospitalization costs to manage 
postprocedure bleeding to gastroenterology practices. 
 
Figure 2: Probability of achieving cost-savings with routine prophylactic clip closure depends on 
clip price. At clip prices greater than $100, the probability of cost-savings was less than 50% 
regardless of clip closure strategy. 
 
Figure 3: Preference toward routine prophylactic clip osure are impacted by the choice of 
clinical strategy, cost of postprocedure bleeding, and clip price, but not technical success of 




Table 1: Average added cost of a bleeding event per patient among all patients undergoing endoscopic resection of a large (≥20 
mm) nonpedunculated polyp with and without clipping of the mucosal defect. Shown are costs and cost-savings to payers with 
several possible routine clip closure strategies. The highest cost-savings were found for prophylactic clip closure after resecting large 
nonpedunculated polyps in the right colon segment. Cost-savings were higher if clip closure was performed among individuals with 
greater medical comorbidity. Base-case is highlighted in bold. 
 
Strategy Medical comorbidities Average cost of 
bleeding event without 
clip closure 
(Column A) 
Average cost of 




(Column A minus B) 
All large colon polyps (≥20 
mm) 
None $319.80 $116.79 $203.01 
1+ comorbidity $453.44 $165.59 $287.85 
1+ major comorbidity $769.98 $281.19 $488.79 
Right colon segment only* None $433.12 $126.96 $306.16 
1+ comorbidity $614.11 $180.02 $422.98 
1+ major comorbidity $1,042.82 $305.68 $737.14 
Left colon segment only** None $62.39 $96.23 -$33.84 
1+ comorbidity $88.47 $136.44 -$47.97 
1+ major comorbidity $150.23 $231.69 -$81.46 
All extra-large colon polyps 
(≥40mm) 
None $253.04 $160.47 $92.57 
1+ comorbidity $358.78 $227.52 $131.26 
1+ major comorbidity $609.25 $386.35 $222.90 
All large colon polyps in 
patients on antithrombotic 
medications 
None $182.19 $133.23 $48.96 
1+ comorbidity $258.32 $188.91 $69.41 
1+ major comorbidity $438.66 $320.79 $117.87 
Costs are averaged among all patients undergoing polypectomy, accounting for the differential bleeding risk based on whether 




Table 2. Maximum clip price to achieve cost-savings in performing prophylactic clip closure. 
 
Clipping Strategy Maximum clip price by medical comorbidities for apatient undergoing polypectomy 
No medical comorbidities At least one medical 
comorbidity (base case) 
At least one major medical 
comorbidity 
All large colon polyps (≥20mm) $46.85 $66.43 $112.80 
Right colon segment only* $70.65 $100.18 $170.11 
Left colon segment only** Not cost-saving Not cost-saving Not cost-saving 
All extra-large colon polyps (≥40 
mm) 
$21.36 $30.29 $51.44 
All large colon polyps in patients 
on antithrombotic medications 
$11.30 $16.02 $27.20 
Patients with increasing medical comorbidities experience higher costs-of-care to manage postprocedure bleeding, resulting in higher 
maximum clip prices for these patients while maintaining cost-savings. Medical comorbidities and major medical comorbidities are 
defined by the 2019 Centers for Medicare & Medicaid Services (CMS) Final Rule for the Acute Inpatient Prospective Payment 






ACRONYMS AND ABBREVIATIONS 
 
CI   confidence interval 
CIN   clinically integrated network 
CMS   Centers for Medicare & Medicaid Services 
EMR   endoscopic mucosal resection 
MC   medical comorbidity 
MMC   major medical comorbidity 
OTS   over-the-scope 
